HDL and Singulex Labs Fined for Violating False Claims Act

April 12, 2015 11:17 PM

2 0

Federal authorities have imposed fines on two US cardiac biomarker labs for bribing doctors to get patient referrals for their programs and for providing blood samples for unnecessary testing. The companies have been also accused for collaborating with Blue Wave Healthcare consultants and offering further incentives to doctors who recommend unnecessary tests. The United States Department of Justice reported that both medical labs have been charged under the False Claims Act.

One of the cardiovascular disease screening labs, HDL (Health Diagnostics Laboratory), has been ordered to pay $47 million and the other one, Singulex Inc., has to pay $1.5 million. Both the companies have agreed to pay the fines in order to settle the civil allegations filed by the Justice Departme...

Also read: Private equity firm Northstar to buy Singapore-listed Innovalues for $239 mln

Read more

To category page